AKRO Supporting Data

This data is derived from company filings and other reputable sources. It has not been generated by AI. It is intended to help verify and validate the AI analysis here. We believe this data to be accurate but we cannot guarentee that it is error free and it should not be relied upon for financial decisions.

Name	Akero Therapeutics, Inc.
Asset Type	EQUITY
Industry	Biotechnology
Market Capitalization	3469843968
Book Value	10.363
Eps	-3.75
Analyst Target Price	77.63636
Forward Pe	-10.254118
Beta	-0.198
Price To Book Ratio	4.205346
Share Price	43.58

Annual Financial Statements

Ratios

	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
New Income Growth Rate	66.09	35.46	11.17	N/A	N/A
EBITDA Growth Rate	66.43	33.60	10.44	N/A	N/A
Free Cash Flow Growth Rate	58.98	57.12	16.11	N/A	N/A
Total Asset Growth Rate	42.33	62.74	82.34	N/A	N/A
Equity Growt	40.13	63.92	93.11	N/A	N/A
Operating Margin	-infT	-infT	-infT	-infT	N/A
EBITDA Margin	-infT	-infT	-infT	-infT	N/A
EBIT Margin	-infT	-infT	-infT	-infT	N/A
Net Profit Margin	-infT	-infT	-infT	-infT	N/A
ROE	-0.34	-0.28	-0.34	-0.60	N/A
ROA	-0.31	-0.26	-0.31	-0.52	N/A
R&D to Revenue	infT	infT	infT	infT	N/A
SG&A to Revenue	infT	infT	infT	infT	N/A
Current Ratio	19.38	29.27	18.61	7.70	N/A
Cash Ratio	8.56	12.24	13.09	5.99	N/A
Cash to Current Assets	0.44	0.42	0.70	0.78	N/A
Debt to Equity	0.05	0.05	0.03	0.01	N/A
Debt to Assets	0.04	0.05	0.03	0.01	N/A
Interest Coverage	-53.00	-47.97	-150.60	-infT	N/A
Liabilities to Equity	0.10	0.08	0.09	0.16	N/A
Equity Multiplier	1.10	1.08	1.09	1.16	N/A
ROIC	-0.31	-0.27	-0.33	-0.60	N/A
Asset Turnover	0.00	0.00	0.00	0.00	N/A
Working Capital Turnover	0.00	0.00	0.00	0.00	N/A
OCF to Sales	-infT	-infT	-infT	-infT	N/A
FCF to OCF	1.00	1.00	1.00	1.00	N/A
Cash Flow Coverage	-6.31	-5.53	-8.45	-52.56	N/A
CapEx Coverage	230.34	N/A	N/A	N/A	N/A
Quality of Income	0.91	0.96	0.83	0.79	N/A
CapEx to Depreciation	-55.50	N/A	N/A	N/A	N/A
Book Value per Share	10.36	9.60	6.97	4.85	N/A

Income Statement

	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Tax Effect Of Unusual Items	0.00	0.00	0.00	0.00	N/A
Tax Rate For Calcs	0.00	0.00	0.00	0.00	N/A
Normalized EBITDA	-247.37M	-148.63M	-111.25M	-100.74M	N/A
Net Income From Continuing Operation Net Minority Interest	-252.06M	-151.76M	-112.03M	-100.78M	N/A
Reconciled Depreciation	18.0K	29.0K	43.0K	41.0K	N/A
EBITDA	-247.37M	-148.63M	-111.25M	-100.74M	N/A
EBIT	-247.39M	-148.66M	-111.29M	-100.78M	N/A
Net Interest Income	33.36M	21.11M	3.12M	109.0K	N/A
Interest Expense	4.67M	3.10M	739.0K	0.00	N/A
Interest Income	38.03M	24.21M	3.86M	109.0K	N/A
Normalized Income	-252.06M	-151.76M	-112.03M	-100.78M	N/A
Net Income From Continuing And Discontinued Operation	-252.06M	-151.76M	-112.03M	-100.78M	N/A
Total Expenses	285.42M	172.87M	115.16M	100.89M	N/A
Total Operating Income As Reported	-285.42M	-172.87M	-115.16M	-100.89M	N/A
Diluted Average Shares	N/A	52.57M	38.98M	34.83M	31.46M
Basic Average Shares	N/A	52.57M	38.98M	34.83M	31.46M
Diluted EPS	N/A	-2.89	-2.87	-2.89	-2.52
Basic EPS	N/A	-2.89	-2.87	-2.89	-2.52
Diluted NI Availto Com Stockholders	-252.06M	-151.76M	-112.03M	-100.78M	N/A
Net Income Common Stockholders	-252.06M	-151.76M	-112.03M	-100.78M	N/A
Net Income	-252.06M	-151.76M	-112.03M	-100.78M	N/A
Net Income Including Noncontrolling Interests	-252.06M	-151.76M	-112.03M	-100.78M	N/A
Net Income Continuous Operations	-252.06M	-151.76M	-112.03M	-100.78M	N/A
Pretax Income	-252.06M	-151.76M	-112.03M	-100.78M	N/A
Other Income Expense	N/A	N/A	3.86M	109.0K	947.0K
Other Non Operating Income Expenses	N/A	N/A	3.86M	109.0K	947.0K
Net Non Operating Interest Income Expense	33.36M	21.11M	3.12M	109.0K	N/A
Interest Expense Non Operating	4.67M	3.10M	739.0K	0.00	N/A
Interest Income Non Operating	38.03M	24.21M	3.86M	109.0K	N/A
Operating Income	-285.42M	-172.87M	-115.16M	-100.89M	N/A
Operating Expense	285.42M	172.87M	115.16M	100.89M	N/A
Research And Development	247.50M	141.80M	85.28M	81.76M	N/A
Selling General And Administration	37.93M	31.07M	29.87M	19.13M	N/A
General And Administrative Expense	37.93M	31.07M	29.87M	19.13M	N/A
Other Gand A	37.93M	31.07M	29.87M	19.13M	N/A
Total Revenue	0.00	0.00	0.00	0.00	N/A
Operating Revenue	0.00	0.00	0.00	0.00	N/A

Balance Sheet

	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Ordinary Shares Number	72.38M	55.75M	46.87M	34.90M	N/A
Share Issued	72.38M	55.75M	46.87M	34.90M	N/A
Total Debt	36.46M	26.30M	10.95M	1.52M	N/A
Tangible Book Value	750.11M	535.31M	326.56M	169.11M	N/A
Invested Capital	785.41M	560.27M	336.10M	169.11M	N/A
Working Capital	730.63M	540.83M	336.09M	168.45M	N/A
Net Tangible Assets	750.11M	535.31M	326.56M	169.11M	N/A
Capital Lease Obligations	1.16M	1.34M	1.40M	1.52M	N/A
Common Stock Equity	750.11M	535.31M	326.56M	169.11M	N/A
Total Capitalization	785.41M	560.27M	336.10M	169.11M	N/A
Total Equity Gross Minority Interest	750.11M	535.31M	326.56M	169.11M	N/A
Stockholders Equity	750.11M	535.31M	326.56M	169.11M	N/A
Gains Losses Not Affecting Retained Earnings	948.0K	270.0K	37.0K	-27.0K	N/A
Other Equity Adjustments	948.0K	270.0K	37.0K	-27.0K	N/A
Retained Earnings	-826.16M	-574.10M	-422.34M	-310.30M	N/A
Additional Paid In Capital	1.58B	1.11B	748.86M	479.44M	N/A
Capital Stock	7.0K	6.0K	5.0K	4.0K	N/A
Common Stock	7.0K	6.0K	5.0K	4.0K	N/A
Total Liabilities Net Minority Interest	75.77M	44.97M	30.01M	26.44M	N/A
Total Non Current Liabilities Net Minority Interest	36.02M	25.84M	10.93M	1.31M	N/A
Other Non Current Liabilities	194.0K	54.0K	305.0K	N/A	N/A
Derivative Product Liabilities	N/A	N/A	305.0K	0.00	N/A
Long Term Debt And Capital Lease Obligation	35.83M	25.78M	10.62M	1.31M	N/A
Long Term Capital Lease Obligation	529.0K	819.0K	1.08M	1.31M	N/A
Long Term Debt	35.30M	24.96M	9.54M	N/A	N/A
Current Liabilities	39.75M	19.13M	19.08M	25.13M	N/A
Current Debt And Capital Lease Obligation	631.0K	522.0K	325.0K	205.0K	N/A
Current Capital Lease Obligation	631.0K	522.0K	325.0K	205.0K	N/A
Pensionand Other Post Retirement Benefit Plans Current	1.17M	1.30M	804.0K	554.0K	N/A
Payables And Accrued Expenses	37.95M	17.31M	17.95M	24.37M	N/A
Current Accrued Expenses	28.93M	10.27M	9.99M	17.66M	N/A
Payables	9.03M	7.04M	7.97M	6.71M	N/A
Accounts Payable	9.03M	7.04M	7.97M	6.71M	N/A
Total Assets	825.89M	580.27M	356.57M	195.55M	N/A
Total Non Current Assets	55.51M	20.31M	1.40M	1.97M	N/A
Other Non Current Assets	N/A	N/A	108.0K	417.0K	201.0K
Investments And Advances	54.75M	19.28M	0.00	N/A	N/A
Investmentin Financial Assets	54.75M	19.28M	0.00	N/A	N/A
Available For Sale Securities	54.75M	19.28M	N/A	N/A	N/A
Net PPE	755.0K	1.03M	1.29M	1.55M	N/A
Gross PPE	755.0K	1.03M	1.29M	1.55M	N/A
Other Properties	755.0K	1.03M	1.29M	1.55M	N/A
Current Assets	770.38M	559.96M	355.17M	193.58M	N/A
Other Current Assets	27.30M	9.95M	3.72M	5.32M	N/A
Prepaid Assets	N/A	N/A	3.72M	5.32M	2.96M
Cash Cash Equivalents And Short Term Investments	743.08M	550.01M	351.45M	188.26M	N/A
Other Short Term Investments	402.84M	315.80M	101.68M	37.77M	N/A
Cash And Cash Equivalents	340.24M	234.21M	249.77M	150.48M	N/A

Cash Flow Statement

	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Free Cash Flow	-231.11M	-145.37M	-92.52M	-79.68M	N/A
Issuance Of Debt	10.00M	15.00M	10.00M	0.00	N/A
Issuance Of Capital Stock	423.08M	335.43M	241.20M	0.00	N/A
Capital Expenditure	-999.0K	N/A	N/A	N/A	-148.0K
Interest Paid Supplemental Data	3.98M	2.48M	441.0K	0.00	N/A
End Cash Position	340.24M	234.21M	249.88M	150.59M	N/A
Beginning Cash Position	234.21M	249.88M	150.59M	187.39M	N/A
Changes In Cash	106.03M	-15.67M	99.29M	-36.80M	N/A
Financing Cash Flow	445.85M	353.32M	255.63M	602.0K	N/A
Cash Flow From Continuing Financing Activities	445.85M	353.32M	255.63M	602.0K	N/A
Net Other Financing Charges	-844.0K	-776.0K	-864.0K	-521.0K	N/A
Proceeds From Stock Option Exercised	13.61M	3.66M	5.30M	1.12M	N/A
Net Common Stock Issuance	423.08M	335.43M	241.20M	0.00	N/A
Common Stock Issuance	423.08M	335.43M	241.20M	0.00	N/A
Net Issuance Payments Of Debt	10.00M	15.00M	10.00M	0.00	N/A
Net Long Term Debt Issuance	10.00M	15.00M	10.00M	0.00	N/A
Long Term Debt Issuance	10.00M	15.00M	10.00M	0.00	N/A
Investing Cash Flow	-109.71M	-223.62M	-63.83M	42.28M	N/A
Cash Flow From Continuing Investing Activities	-109.71M	-223.62M	-63.83M	42.28M	N/A
Net Investment Purchase And Sale	-108.71M	-223.62M	-63.83M	42.28M	N/A
Sale Of Investment	407.33M	209.50M	37.62M	85.84M	N/A
Purchase Of Investment	-516.04M	-433.12M	-101.45M	-43.56M	N/A
Net Intangibles Purchase And Sale	-999.0K	N/A	N/A	N/A	N/A
Purchase Of Intangibles	-999.0K	N/A	N/A	N/A	N/A
Net PPE Purchase And Sale	N/A	N/A	N/A	0.00	-148.0K
Purchase Of PPE	N/A	N/A	N/A	0.00	-148.0K
Operating Cash Flow	-230.11M	-145.37M	-92.52M	-79.68M	N/A
Cash Flow From Continuing Operating Activities	-230.11M	-145.37M	-92.52M	-79.68M	N/A
Change In Working Capital	3.00M	-6.67M	-4.46M	9.73M	N/A
Change In Other Working Capital	N/A	N/A	N/A	N/A	-2.0K
Change In Other Current Liabilities	-259.0K	-231.0K	-206.0K	-182.0K	N/A
Change In Payables And Accrued Expense	20.61M	301.0K	-6.37M	12.01M	N/A
Change In Accrued Expense	18.60M	946.0K	-7.33M	8.74M	N/A
Change In Payable	2.01M	-645.0K	968.0K	3.27M	N/A
Change In Account Payable	2.01M	-645.0K	968.0K	3.27M	N/A
Change In Prepaid Assets	-17.35M	-6.74M	2.11M	-2.10M	N/A
Other Non Cash Items	1.86M	1.02M	421.0K	203.0K	N/A
Stock Based Compensation	29.70M	21.50M	23.24M	10.05M	N/A
Amortization Of Securities	-13.12M	-9.55M	-12.0K	1.07M	N/A
Depreciation Amortization Depletion	18.0K	29.0K	43.0K	41.0K	N/A
Depreciation And Amortization	18.0K	29.0K	43.0K	41.0K	N/A
Depreciation	18.0K	29.0K	43.0K	41.0K	N/A
Operating Gains Losses	498.0K	71.0K	280.0K	5.0K	N/A
Gain Loss On Investment Securities	517.0K	79.0K	264.0K	N/A	N/A
Net Foreign Currency Exchange Gain Loss	-19.0K	-8.0K	16.0K	5.0K	N/A
Net Income From Continuing Operations	-252.06M	-151.76M	-112.03M	-100.78M	N/A

Quarterly Financial Statements

Ratios

	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31
New Income Growth Rate	-3.69	29.86	4.95	-3.34	N/A
EBITDA Growth Rate	-3.71	30.50	4.59	-3.56	N/A
Free Cash Flow Growth Rate	-4.73	20.48	66.34	-27.74	N/A
Total Asset Growth Rate	1.02	-5.49	-5.17	57.21	N/A
Equity Growt	1.60	-7.49	-5.69	58.09	N/A
Operating Margin	-infT	-infT	-infT	-infT	-infT
EBITDA Margin	-infT	-infT	-infT	-infT	-infT
EBIT Margin	-infT	-infT	-infT	-infT	-infT
Net Profit Margin	-infT	-infT	-infT	-infT	-infT
ROE	-0.09	-0.10	-0.07	-0.06	-0.10
ROA	-0.08	-0.09	-0.06	-0.06	-0.10
R&D to Revenue	infT	infT	infT	infT	infT
SG&A to Revenue	infT	infT	infT	infT	infT
Current Ratio	19.38	17.25	24.89	30.12	29.27
Cash Ratio	8.56	7.30	9.96	20.62	12.24
Cash to Current Assets	0.44	0.42	0.40	0.68	0.42
Debt to Equity	0.05	0.05	0.05	0.04	0.05
Debt to Assets	0.04	0.04	0.04	0.04	0.05
Interest Coverage	-57.35	-57.35	-44.48	-52.83	-60.52
Liabilities to Equity	0.10	0.11	0.08	0.08	0.08
Equity Multiplier	1.10	1.11	1.08	1.08	1.08
ROIC	-0.09	-0.09	-0.07	-0.06	-0.10
Asset Turnover	0.00	0.00	0.00	0.00	0.00
Working Capital Turnover	0.00	0.00	0.00	0.00	0.00
OCF to Sales	-infT	-infT	-infT	-infT	-infT
FCF to OCF	1.00	1.00	1.02	1.00	1.00
Cash Flow Coverage	-1.84	-1.94	-1.58	-0.97	-1.85
Quality of Income	0.96	0.97	1.03	0.66	0.88
Book Value per Share	10.36	10.61	11.53	12.24	9.60

Income Statement

	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31
Tax Effect Of Unusual Items	0.00	0.00	0.00	0.00	0.00
Tax Rate For Calcs	0.00	0.00	0.00	0.00	0.00
Normalized EBITDA	-68.81M	-71.46M	-54.76M	-52.35M	-54.29M
Net Income From Continuing Operation Net Minority Interest	-70.02M	-72.70M	-55.99M	-53.34M	-55.19M
Reconciled Depreciation	15.0K	1.0K	1.0K	1.0K	2.0K
EBITDA	-68.81M	-71.46M	-54.76M	-52.35M	-54.29M
EBIT	-68.82M	-71.46M	-54.76M	-52.35M	-54.29M
Net Interest Income	8.00M	9.00M	9.75M	6.61M	23.31M
Interest Expense	1.20M	1.25M	1.23M	991.0K	897.0K
Interest Income	9.20M	10.24M	10.98M	7.60M	N/A
Normalized Income	-70.02M	-72.70M	-55.99M	-53.34M	-55.19M
Net Income From Continuing And Discontinued Operation	-70.02M	-72.70M	-55.99M	-53.34M	-55.19M
Total Expenses	78.03M	81.70M	65.74M	59.95M	61.87M
Total Operating Income As Reported	-78.03M	-81.70M	-65.74M	-59.95M	-61.87M
Diluted Average Shares	70.57M	69.44M	69.16M	59.31M	N/A
Basic Average Shares	70.57M	69.44M	69.16M	59.31M	N/A
Diluted EPS	-0.99	-1.05	-0.81	-0.90	N/A
Basic EPS	-0.99	-1.05	-0.81	-0.90	N/A
Diluted NI Availto Com Stockholders	-70.02M	-72.70M	-55.99M	-53.34M	-55.19M
Net Income Common Stockholders	-70.02M	-72.70M	-55.99M	-53.34M	-55.19M
Net Income	-70.02M	-72.70M	-55.99M	-53.34M	-55.19M
Net Income Including Noncontrolling Interests	-70.02M	-72.70M	-55.99M	-53.34M	-55.19M
Net Income Continuous Operations	-70.02M	-72.70M	-55.99M	-53.34M	-55.19M
Pretax Income	-70.02M	-72.70M	-55.99M	-53.34M	-55.19M
Other Income Expense	N/A	N/A	N/A	N/A	N/A
Other Non Operating Income Expenses	N/A	N/A	N/A	N/A	N/A
Net Non Operating Interest Income Expense	8.00M	9.00M	9.75M	6.61M	23.31M
Interest Expense Non Operating	1.20M	1.25M	1.23M	991.0K	897.0K
Interest Income Non Operating	9.20M	10.24M	10.98M	7.60M	N/A
Operating Income	-78.03M	-81.70M	-65.74M	-59.95M	-61.87M
Operating Expense	78.03M	81.70M	65.74M	59.95M	61.87M
Research And Development	69.29M	72.23M	55.32M	50.65M	53.39M
Selling General And Administration	8.73M	9.47M	10.42M	9.30M	8.48M
General And Administrative Expense	8.73M	9.47M	10.42M	9.30M	8.48M
Other Gand A	8.73M	9.47M	10.42M	9.30M	8.48M
Total Revenue	0.00	0.00	0.00	0.00	0.00
Operating Revenue	0.00	0.00	0.00	0.00	0.00

Balance Sheet

	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31
Ordinary Shares Number	72.38M	69.61M	69.21M	69.15M	55.75M
Share Issued	72.38M	69.61M	69.21M	69.15M	55.75M
Total Debt	36.46M	36.36M	36.27M	36.19M	26.30M
Tangible Book Value	750.11M	738.33M	798.07M	846.25M	535.31M
Invested Capital	785.41M	773.45M	833.03M	881.06M	560.27M
Working Capital	730.63M	703.60M	744.84M	881.02M	540.83M
Net Tangible Assets	750.11M	738.33M	798.07M	846.25M	535.31M
Capital Lease Obligations	1.16M	1.24M	1.31M	1.39M	1.34M
Common Stock Equity	750.11M	738.33M	798.07M	846.25M	535.31M
Total Capitalization	785.41M	773.45M	833.03M	881.06M	560.27M
Total Equity Gross Minority Interest	750.11M	738.33M	798.07M	846.25M	535.31M
Stockholders Equity	750.11M	738.33M	798.07M	846.25M	535.31M
Gains Losses Not Affecting Retained Earnings	948.0K	2.10M	-261.0K	-79.0K	270.0K
Other Equity Adjustments	948.0K	2.10M	-261.0K	-79.0K	270.0K
Retained Earnings	-826.16M	-756.13M	-683.43M	-627.44M	-574.10M
Additional Paid In Capital	1.58B	1.49B	1.48B	1.47B	1.11B
Capital Stock	7.0K	7.0K	7.0K	7.0K	6.0K
Common Stock	7.0K	7.0K	7.0K	7.0K	6.0K
Total Liabilities Net Minority Interest	75.77M	79.22M	66.98M	65.99M	44.97M
Total Non Current Liabilities Net Minority Interest	36.02M	35.93M	35.80M	35.73M	25.84M
Other Non Current Liabilities	194.0K	N/A	164.0K	178.0K	54.0K
Derivative Product Liabilities	N/A	203.0K	N/A	N/A	N/A
Long Term Debt And Capital Lease Obligation	35.83M	35.73M	35.64M	35.55M	25.78M
Long Term Capital Lease Obligation	529.0K	605.0K	679.0K	750.0K	819.0K
Long Term Debt	35.30M	35.12M	34.96M	34.80M	24.96M
Current Liabilities	39.75M	43.29M	31.17M	30.26M	19.13M
Current Debt And Capital Lease Obligation	631.0K	631.0K	629.0K	640.0K	522.0K
Current Capital Lease Obligation	631.0K	631.0K	629.0K	640.0K	522.0K
Current Debt	N/A	N/A	N/A	N/A	N/A
Other Current Borrowings	N/A	N/A	N/A	N/A	N/A
Pensionand Other Post Retirement Benefit Plans Current	1.17M	4.37M	3.12M	2.23M	1.30M
Payables And Accrued Expenses	37.95M	38.29M	27.42M	27.39M	17.31M
Current Accrued Expenses	28.93M	13.07M	12.86M	13.61M	10.27M
Payables	9.03M	25.22M	14.57M	13.78M	7.04M
Accounts Payable	9.03M	25.22M	14.57M	13.78M	7.04M
Total Assets	825.89M	817.55M	865.04M	912.24M	580.27M
Total Non Current Assets	55.51M	70.66M	89.03M	963.0K	20.31M
Investments And Advances	54.75M	69.82M	88.13M	0.00	19.28M
Investmentin Financial Assets	54.75M	69.82M	88.13M	0.00	19.28M
Available For Sale Securities	54.75M	69.82M	88.13M	N/A	19.28M
Net PPE	755.0K	835.0K	900.0K	963.0K	1.03M
Gross PPE	755.0K	835.0K	900.0K	963.0K	1.03M
Other Properties	755.0K	835.0K	900.0K	963.0K	1.03M
Current Assets	770.38M	746.89M	776.01M	911.28M	559.96M
Other Current Assets	27.30M	29.64M	15.82M	7.62M	9.95M
Cash Cash Equivalents And Short Term Investments	743.08M	717.25M	760.19M	903.66M	550.01M
Other Short Term Investments	402.84M	401.18M	449.84M	279.81M	315.80M
Cash And Cash Equivalents	340.24M	316.06M	310.36M	623.85M	234.21M

Cash Flow Statement

	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31
Free Cash Flow	-67.09M	-70.42M	-58.45M	-35.14M	-48.63M
Issuance Of Debt	0.00	0.00	0.00	10.00M	0.00
Issuance Of Capital Stock	67.64M	0.00	0.00	355.44M	0.00
Interest Paid Supplemental Data	1.03M	1.09M	1.09M	768.0K	768.0K
End Cash Position	340.24M	316.06M	310.36M	623.85M	234.21M
Beginning Cash Position	316.06M	310.36M	623.85M	234.21M	269.55M
Changes In Cash	24.17M	5.71M	-313.50M	389.65M	-35.34M
Financing Cash Flow	75.99M	3.07M	-150.0K	366.94M	502.0K
Cash Flow From Continuing Financing Activities	75.99M	3.07M	-150.0K	366.94M	502.0K
Net Other Financing Charges	-29.0K	-64.0K	-477.0K	-274.0K	-31.0K
Proceeds From Stock Option Exercised	8.38M	3.13M	327.0K	1.77M	533.0K
Net Common Stock Issuance	67.64M	0.00	0.00	355.44M	0.00
Common Stock Issuance	67.64M	0.00	0.00	355.44M	0.00
Net Issuance Payments Of Debt	0.00	0.00	0.00	10.00M	0.00
Net Long Term Debt Issuance	0.00	0.00	0.00	10.00M	0.00
Long Term Debt Issuance	0.00	0.00	0.00	10.00M	0.00
Investing Cash Flow	15.27M	73.07M	-255.90M	57.85M	12.79M
Cash Flow From Continuing Investing Activities	15.27M	73.07M	-255.90M	57.85M	12.79M
Net Investment Purchase And Sale	15.27M	73.07M	-254.90M	57.85M	12.79M
Sale Of Investment	95.00M	131.00M	84.51M	96.83M	71.00M
Purchase Of Investment	-79.73M	-57.93M	-339.41M	-38.98M	-58.21M
Net Intangibles Purchase And Sale	0.00	0.00	N/A	N/A	N/A
Purchase Of Intangibles	0.00	0.00	N/A	N/A	N/A
Operating Cash Flow	-67.09M	-70.42M	-57.45M	-35.14M	-48.63M
Cash Flow From Continuing Operating Activities	-67.09M	-70.42M	-57.45M	-35.14M	-48.63M
Change In Working Capital	-1.39M	-1.80M	-6.88M	13.07M	3.93M
Change In Other Current Liabilities	-68.0K	-66.0K	-63.0K	-62.0K	-60.0K
Change In Payables And Accrued Expense	-3.47M	12.02M	1.25M	10.80M	-7.07M
Change In Accrued Expense	12.64M	1.45M	157.0K	4.34M	-2.84M
Change In Payable	-16.11M	10.57M	1.09M	6.46M	-4.23M
Change In Account Payable	-16.11M	10.57M	1.09M	6.46M	-4.23M
Change In Prepaid Assets	2.15M	-13.76M	-8.07M	2.34M	11.05M
Other Non Cash Items	239.0K	228.0K	1.22M	174.0K	180.0K
Stock Based Compensation	7.18M	7.47M	7.66M	7.40M	6.12M
Amortization Of Securities	-3.01M	-3.74M	-3.45M	-2.92M	-3.65M
Depreciation Amortization Depletion	15.0K	1.0K	1.0K	1.0K	2.0K
Depreciation And Amortization	15.0K	1.0K	1.0K	1.0K	2.0K
Depreciation	15.0K	1.0K	1.0K	1.0K	2.0K
Operating Gains Losses	-95.0K	125.0K	-10.0K	478.0K	-21.0K
Gain Loss On Investment Securities	-9.0K	39.0K	-13.0K	500.0K	-39.0K
Net Foreign Currency Exchange Gain Loss	-86.0K	86.0K	3.0K	-22.0K	18.0K
Net Income From Continuing Operations	-70.02M	-72.70M	-55.99M	-53.34M	-55.19M

Legal Disclaimer

The information contained on this website and associated documents, including all text, data, analyses, opinions, and forward-looking statements, is provided solely for general informational purposes and does not constitute financial, investment, legal, or tax advice. The content has been generated by an artificial intelligence tool using publicly available data and company filings. Although every effort has been made to ensure accuracy, the information is provided “as is” without any warranty—express or implied—of completeness, accuracy, reliability, or suitability for any purpose.

Not Regulated Advice

No FCA Authorization: We are not authorized or regulated by the Financial Conduct Authority (FCA) or any other financial regulatory body to offer investment advice or recommendations. Nothing in this report should be construed as a solicitation, recommendation, or endorsement to buy, sell, or hold any security or financial instrument.
Independent Decision-Making: Investors are strongly encouraged to conduct their own research and consult with a licensed financial advisor or other professional before making any financial decisions. Reliance on the information provided herein is solely at your own risk.

Forward-Looking Statements

This report may contain forward-looking statements, which are based on current expectations, assumptions, and projections that involve risks and uncertainties. Actual results may differ materially from those expressed or implied by these statements. We do not undertake any obligation to update or revise any forward-looking statements in light of new information or future developments.

Limitation of Liability

Under no circumstances shall Aipha.io or its affiliates, employees, or agents be liable for any direct, indirect, incidental, consequential, or other damages arising out of or in connection with the use of, or reliance on, the information contained in this report—even if advised of the possibility of such damages. This includes, without limitation, any loss of profit, revenue, or data.

Use at Your Own Risk

By using this report, you acknowledge that you have read and understood this disclaimer and agree that any reliance on the information provided is at your own risk. [Your Company Name/Aipha.io] expressly disclaims any and all liability for any loss or damage of any kind incurred as a result of any use of this report.